Polypeptide of recombinant human bone morphogenetic protein-2

a morphogenetic protein and polypeptide technology, applied in the field of biotechnology, can solve the problems of difficult to meet clinical needs, low bone bmp-2 level, limited fresh human bone source, etc., and achieve good ectopic osteoinduction activity, good renaturation and purification effect, and easy denature and purification

Inactive Publication Date: 2020-01-30
ZHEJIANG RISING BIOTECH CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent describes a new way to make a protein called recombinant human bone morphiogenetic protein-2 (rhBMP-2). The new method allows for better movement and purification of the protein, which makes it easier to use in bone repair. The use of a specific nucleotide sequence and a particular type of cell makes the protein produced have better biological activity and can be easily denatured and purified. The purified protein is also more stable, which means it can be stored for longer periods of time and remains active. Overall, this new method makes it possible to produce a highly active and stable rhBMP-2 protein, which has broad market potential.

Problems solved by technology

However, the source of fresh human bones is limited and bone BMP-2 level is low in the bone, only 1-2 μg per kg of cortical bone, which is difficult to meet clinical needs.
Moreover, its extraction process is complicated, and its purity and activity could not be guaranteed.
The product prepared by a eukaryotic expression system has high activity, but it has the drawbacks of low expression level, high production cost, and unsuitable for mass production, etc.
As prokaryotic expression systems do not have the process of post-translational modification of polypeptide chains by eukaryotic cells, the eukaryotic gene proteins cannot be correctly folded and post-translationally processed (such as forming disulfide bonds, glycosylation, polymerization, protease degradation, etc.), which restricts their biological activity and availability.
The prepared rhBMP-2 using the existing several kinds of rhBMP-2 mature peptide fragments has poor renaturation and purification effects, and the final product has low biological activity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide of recombinant human bone morphogenetic protein-2
  • Polypeptide of recombinant human bone morphogenetic protein-2
  • Polypeptide of recombinant human bone morphogenetic protein-2

Examples

Experimental program
Comparison scheme
Effect test

example 1

Design of Novel Amino Acid Sequence of rhBMP-2 and Construction of Recombinant rhBMP-2 Expression Vector

[0026]1. In One Embodiment, the Polypeptide of rhBMP-2 has the Amino Acid Sequence as Follows:

(SEQ ID NO: 1)KRLK SSCKR HPLYV DFSDV GWNDW IVAPP GYHAF YCHGECPFPL ADHLN STNHA IVQTL VNSVN SKIPK ACCVP TELSAISMLY LDENE KVVLK NYQDM VVEGC GCR.

[0027]Further, the N-terminal of the above amino acid sequence is added with methionine M encoded by the initiation codon (ATG). The amino acid sequence is as follows:

(SEQ ID NO: 2)MKRLK SSCKR HPLYV DFSDV GWNDW IVAPP GYHAF YCHGECPFPL ADHLN STNHA IVQTL VNSVN SKIPK ACCVP TELSAISMLY LDENE KVVLK NYQDM VVEGC GCR.

[0028]Further, by optimizing the codons, all rare codons are removed to become E. coli-preferred codons, at the same time, the restriction site BamHI (GGATCC) is added at the terminal. The optimized DNA sequences are as follows:

(SEQ ID NO: 3)ATGAAACGTCTGAAAAGCAGCTGCAAACGTCACCCGCTGTACGTTGATTTCAGCGATGTTGGCTGGAACGATTGGATCGTTGCGCCGCCGGGCTACCACGCGTTCTA...

example 3

In Vitro Activity Assay of Recombinant rhBMP-2 in C2C12 Cells

[0056]C2C12 cells (mesenchymal stem cells) were cultured in DMEM high glucose medium (containing 10% fetal bovine serum, 100 U / mL penicillin and 100 g / mL streptomycin) under the conditions of 37° C. and 5% CO2 and digested with 0.25% trypsin for passage every 1-2d. C2C12 cells were inoculated in a 24-well plate, and when cell fusion reached around 30%, recombinant rhBMP-2 was added for continuous culture. After 5 days of culture, the medium was discarded and washed twice with pre-cooled PBS buffer. After lysed with lysate for 5 min, the supernatant was centrifuged and the activity of alkaline phosphatase (ALP) was quantitatively determined according to the instructions of the kit.

[0057]Controlled Trial:

[0058]In order to compare the biological activities of recombinant rhBMP-2 having the novel amino acid sequences of the present invention, three kinds of reported polypeptides were used for controlled trial. The engineered b...

example 4

Effect of Three Vectors on Mouse Muscle Ectopic Osteogenesis Induced by Recombinant RhBMP-2

[0068]The recombinant rhBMP-2 aqueous solution was mixed with high-concentration gelatin, chitosan or natural coral, and the recombinant rhBMP-2 was uniformly combined with the three vectors to form a composite material by vacuumizing. Each vector contained 100 μg rhBMP-2, which was lyophilized and disinfected by ethylene oxide for later use.

[0069]Six normal ICR male mice were randomly divided into three groups, two mice in each group. After anesthesia with 1% sodium pentobarbital, the hind limbs were depilated and disinfected, and the skin was cut to separate the spatium intermusculare, and then implanted with a certain amount of the above composite material. Among them, the implanted materials in the first group used high concentration gelatin as a vector, and chitosan was used as a vector in the second group, and natural coral was used as a vector in the third group. Mice were given antibio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a field of biotechnology. It discloses a novel amino acid sequence of recombinant human bone morphogenetic protein-2 (rhBMP-2) and encoded nucleotide sequences thereof, and a method for preparing rhBMP-2. In the present invention, by further optimizing the nucleotide sequence of rhBMP-2, novel amino acid sequence of rhBMP-2 that can express good ectopic induced osteogenic activity and has good renaturation and purification effect is screened out. The engineered bacteria constructed by the present invention can induce the production of recombinant rhBMP-2 protein with an expression level of about 55%, and the produced target protein is more easily denatured and purified than the existing recombinant rhBMP-2, with better denaturation and purification effect and higher osteoinductive activity.

Description

CROSS REFERENCE TO RELATED APPLICATION[0001]The present application claims the benefit of Chinese Patent Application No. 201810818738.7, filed on Jul. 24, 2018. The content of the application including all tables, diagrams and claims is incorporated hereby as reference in its entirety.FIELD OF THE INVENTION[0002]The present invention relates to a field of biotechnology, and in particular to a novel amino acid sequence of recombinant human bone morphogenetic protein-2 (rhBMP-2) and encoded nucleotide sequences thereof, and a method for preparing rhBMP-2.BACKGROUND OF THE INVENTION[0003]Bone morphogenetic protein (BMP) is a member of the transforming growth factor (TGF)-β superfamily. With unique osteoinductive activity, BMP has important functions in the repair of bone segment defects of bones and joints and spinal fusion, etc. At present, a variety of BMPs have been isolated from bone matrix of various animals such as cattle, pigs, sheep, rabbits, mice and human, etc., of which, hum...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C07K14/51C07K1/18
CPCC07K14/51C07K1/18C12N15/70C12N2800/22C12N15/63C12N15/09C07K1/16C12N15/66C07K1/14
InventorCAO, JIANXIN
OwnerZHEJIANG RISING BIOTECH CO LTD